Antibody Responses in Contacts of COVID-19 Patients
Antibody Responses in Contacts of COVID-19 Sufferers
The SARS-CoV-2 belongs to the genus β which has been confirmed to be extremely infectious by analysis. (https://www.who.int/emergencies/ illnesses/novel-coronavirus-2019/situation-reports).
The 4 main structural proteins of coronavirus are the spike floor glycoprotein (S), small envelope protein (E), matrix protein (M), and nucleocapsid protein (N). The spike protein (S) of coronavirus is a kind I transmembrane glycoprotein and mediates the doorway to human respiratory epithelial cells by interacting with cell floor receptor angiotensin-converting enzyme 2 (ACE2) .
The S protein incorporates distinct useful domains close to the amino (S1) and carboxy (S2) termini, the peripheral S1 portion can independently bind mobile receptors whereas the integral membrane S2 portion is required to mediate fusion of viral and mobile membranes .
The nucleocapsid protein (N) varieties complexes with genomic RNA, interacts with the viral membrane protein throughout virion meeting and performs a important position in enhancing the effectivity of virustranscription and meeting .
The prognosis of COVID-19 relies primarily on scientific traits, CT imaging and some laboratory assessments. Though some signs and laboratory parameters have indicative values in confirmed sufferers, they aren’t distinctive to SARSCoV-2 an infection.
Essentially the most used and dependable check for prognosis of COVID-19 has been the RT-PCR check carried out utilizing nasopharyngeal swabs.
A wide range of RNAgenetargets are utilized by completely different producers, with most assessments concentrating on 1 or extra of the envelope (env), nucleocapsid (N), spike (S), RNA-dependent RNA polymerase (RdRp), and ORF1 genes .
Anti-Galectin 1/Lgals1 Antibody |
|||
| A00470-1 | BosterBio | 100ug/vial | EUR 334 |
Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
Recombinant Human Galectin-1 Protein |
|||
| PROTP09382-1 | BosterBio | 50ug | EUR 317 |
|
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues. |
|||
Anti-Galectin-3 Monoclonal Antibody |
|||
| M00621-1 | BosterBio | 100ul | EUR 397 |
|
Description: Mouse Monoclonal Galectin-3 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat. |
|||
anti-Galectin 1 |
|||
| YF-PA12945 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to Galectin 1 |
|||
Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | EUR 349 |
Anti-Galectin 1 Antibody |
|||
| A00470-2 | BosterBio | 100ug/vial | EUR 294 |
Anti-Galectin-1 antibody |
|||
| STJ98716 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Galectin-1. |
|||
Anti-Galectin-1 antibody |
|||
| STJ93201 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Galectin-1. |
|||
anti- Galectin-1 antibody |
|||
| FNab03314 | FN Test | 100µg | EUR 505.25 |
|
Description: Antibody raised against Galectin-1 |
|||
anti- Galectin-1 antibody |
|||
| FNab03315 | FN Test | 100µg | EUR 548.75 |
|
Description: Antibody raised against Galectin-1 |
|||
Anti-Galectin-1 antibody |
|||
| PAab03314 | Lifescience Market | 100 ug | EUR 355 |
Anti-Galectin 1 (1A8) |
|||
| YF-MA13984 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to Galectin 1 |
|||
Anti-Galectin 1/LGALS1 Antibody |
|||
| PA1422 | BosterBio | 100ug/vial | EUR 334 |
Anti-Galectin 1/LGALS1 Antibody |
|||
| PB9240 | BosterBio | 100ug/vial | EUR 334 |
Anti-Galectin 1/Lgals1 Antibody |
|||
| A00470 | BosterBio | 100ug/vial | EUR 334 |
Anti-Galectin 1 Biotinylated Antibody |
|||
| A00470-Biotin | BosterBio | 50ug/vial | EUR 294 |
Anti-galectin-1 (mouse) antibody |
|||
| STJ72519 | St John's Laboratory | 100 µg | EUR 359 |
anti-Galectin 1 (1E8-1B2) |
|||
| LF-MA10174 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to Galectin 1 |
|||
Anti-Galectin-13 (GAL13) / Placental Protein 13 (PP13) Monoclonal Antibody |
|||
| M08143-1 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Mouse Monoclonal Galectin-13 (GAL13) / Placental Protein 13 (PP13) Antibody. Validated in IHC and tested in Human. |
|||
Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
anti-Galectin 3 |
|||
| YF-PA12946 | Abfrontier | 50 ug | EUR 363 |
|
Description: Mouse polyclonal to Galectin 3 |
|||
anti-Galectin 3 |
|||
| YF-PA12947 | Abfrontier | 100 ul | EUR 403 |
|
Description: Rabbit polyclonal to Galectin 3 |
|||
anti-Galectin 3 |
|||
| YF-PA12948 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to Galectin 3 |
|||
anti-Galectin 8 |
|||
| YF-PA12951 | Abfrontier | 50 ul | EUR 363 |
|
Description: Mouse polyclonal to Galectin 8 |
|||
anti-Galectin 3 |
|||
| YF-PA24079 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to Galectin 3 |
|||
anti-galectin 9 |
|||
| YF-PA24081 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to galectin 9 |
|||
anti-Galectin 13 |
|||
| YF-PA18585 | Abfrontier | 50 ug | EUR 363 |
|
Description: Mouse polyclonal to Galectin 13 |
|||
Anti-human Galectin-3 antibody |
|||
| STJ15100163 | St John's Laboratory | 250 µg | EUR 336 |
|
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation |
|||
LGALS7 Human, Galectin-7 Human Recombinant Protein, His Tag |
|||
| PROTP47929-1 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: Galectin-7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 156 amino acids (1-136 a.a.) and having a molecular mass of 17.2kDa. ;The Galectin-7 is purified by proprietary chromatographic techniques. |
|||
LGALS3 Human, Galectin-3 Human Recombinant Protein, His Tag |
|||
| PROTP17931-1 | BosterBio | Regular: 25ug | EUR 317 |
|
Description: LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 270 amino acids (1-250 a.a.) and having a molecular mass of 28.3 kDa._x000D_ The LGALS3 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. _x000D_ |
|||
LGALS8 Human, Galectin-8 Human Recombinant Protein, His Tag |
|||
| PROTO00214-1 | BosterBio | Regular: 10ug | EUR 317 |
|
Description: LGALS8 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 337 amino acids (1-317 a.a.) and having a molecular mass of 37.9 kDa. The LGALS8 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. |
|||
Human Galectin-3 (Gal-3) AssayMax ELISA Kit |
|||
| EG3311-1 | AssayPro | 96 Well Plate | EUR 477 |
Human Galectin-4 (Gal-4) AssayMax ELISA Kit |
|||
| EG3312-1 | AssayPro | 96 Well Plate | EUR 477 |
Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HU | Cusabio |
|
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HUb1 | Cusabio |
|
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
Human Galectin 1 Protein |
|||
| 20-abx066725 | Abbexa |
|
|
Recombinant Human Galectin-1 |
|||
| 7-00427 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00428 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00429 | CHI Scientific | 1mg | Ask for price |
Galectin-1, human recombinant |
|||
| 4648-10 | Biovision | EUR 142 | |
Galectin-1, human recombinant |
|||
| 4648-1000 | Biovision | EUR 1648 | |
Galectin-1, human recombinant |
|||
| 4648-50 | Biovision | EUR 262 | |
Anti-Galectin-3 antibody |
|||
| STJ16100369 | St John's Laboratory | 1 mL | EUR 1047 |
Anti-Galectin-3 antibody |
|||
| STJ16100782 | St John's Laboratory | 100 µg | EUR 720 |
Anti-Galectin-3 antibody |
|||
| STJ180106 | St John's Laboratory | 0.1 ml | EUR 212 |
Anti-Galectin 3 antibody |
|||
| STJ190057 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Unconjugated Mouse monoclonal to Galectin 3 (AS1A24) |
|||
Anti-Galectin-9 Antibody |
|||
| A03415 | BosterBio | 100ul | EUR 397 |
|
Description: Rabbit Polyclonal Antibody for Galectin-9 Antibody (LGALS9) detection.tested for WB in Human, Mouse, Rat. |
|||
Anti-Galectin-3 antibody |
|||
| STJ96945 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Galectin-3 is a protein encoded by the LGALS3 gene which is approximately 26,1 kDa. Galectin-3 is localised to the cytoplasm and nucleus. It is involved in NF-kappaB signalling, advanced glycosylation end product receptor signalling and cell adhesion. It is a galactose-specific lectin which binds IgE and may mediate the stimulation by CSPG4 of endothelial cells migration along with the alpha-3, beta-1 integrin. It is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. Galectin-3 is expressed mainly in the colonic epithelium and is also abundantly expressed in activated macrophages. Mutations in the LGALS3 gene may result in follicular adenoma and thyroid cancer. STJ96945 was developed from clone 6G2 and was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. This antibody detects endogenous galectin-3 proteins. |
|||
Anti-Galectin-3 antibody |
|||
| STJ97549 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Mouse monoclonal to Galectin-3 (6B8). |
|||
Anti-Galectin-3 antibody |
|||
| STJ97550 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Mouse monoclonal to Galectin-3 (8D7). |
|||
Anti-Galectin-3 antibody |
|||
| STJ97551 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Mouse monoclonal to Galectin-3 (5D9). |
|||
Anti-Galectin-3 antibody |
|||
| STJ97601 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Mouse monoclonal to Galectin-3 (2F9). |
|||
Anti-Galectin-3 antibody |
|||
| STJ97604 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Mouse monoclonal to Galectin-3 (16E6). |
|||
Anti-Galectin-3 antibody |
|||
| STJ97605 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Mouse monoclonal to Galectin-3 (1H4). |
|||
Anti-Galectin-3 antibody |
|||
| STJ97715 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Mouse monoclonal to Galectin-3. |
|||
Anti-Galectin-2 antibody |
|||
| STJ93202 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Galectin-2. |
|||
Anti-Galectin-4 antibody |
|||
| STJ93203 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Galectin-4. |
|||
Anti-Galectin-7 antibody |
|||
| STJ93204 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Galectin-7. |
|||
Anti-Galectin-8 antibody |
|||
| STJ93205 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Galectin-8. |
|||
Anti-Galectin-9 antibody |
|||
| STJ93206 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Galectin-9. |
|||
Anti-Galectin 3 antibody |
|||
| STJ73098 | St John's Laboratory | 100 µg | EUR 359 |
anti- Galectin 2 antibody |
|||
| FNab03310 | FN Test | 100µg | EUR 585 |
|
Description: Antibody raised against Galectin 2 |
|||
anti- Galectin 4 antibody |
|||
| FNab03311 | FN Test | 100µg | EUR 505.25 |
|
Description: Antibody raised against Galectin 4 |
|||
anti- Galectin 8 antibody |
|||
| FNab03312 | FN Test | 100µg | EUR 505.25 |
|
Description: Antibody raised against Galectin 8 |
|||
anti- Galectin 9 antibody |
|||
| FNab03313 | FN Test | 100µg | EUR 505.25 |
|
Description: Antibody raised against Galectin 9 |
|||
anti- Galectin-3 antibody |
|||
| FNab03316 | FN Test | 100µg | EUR 505.25 |
|
Description: Antibody raised against Galectin-3 |
|||
anti- Galectin-3 antibody |
|||
| FNab03317 | FN Test | 100µg | EUR 548.75 |
|
Description: Antibody raised against Galectin-3 |
|||
anti- Galectin-7 antibody |
|||
| FNab03318 | FN Test | 100µg | EUR 505.25 |
|
Description: Antibody raised against Galectin-7 |
|||
anti-Galectin-3 (6G2) |
|||
| LF-MA20336 | Abfrontier | 100 ug | EUR 354 |
|
Description: Mouse monoclonal to Galectin-3 |
|||
Anti-Galectin 2 antibody |
|||
| PAab03310 | Lifescience Market | 100 ug | EUR 412 |
Anti-Galectin 4 antibody |
|||
| PAab03311 | Lifescience Market | 100 ug | EUR 355 |
Anti-Galectin 8 antibody |
|||
| PAab03312 | Lifescience Market | 100 ug | EUR 355 |
Anti-Galectin 9 antibody |
|||
| PAab03313 | Lifescience Market | 100 ug | EUR 355 |
Anti-Galectin-3 antibody |
|||
| PAab03316 | Lifescience Market | 100 ug | EUR 355 |
Anti-Galectin-7 antibody |
|||
| PAab03318 | Lifescience Market | 100 ug | EUR 355 |
Anti-Galectin 8 (3E5) |
|||
| YF-MA13986 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to Galectin 8 |
|||
Anti-galectin-1 (mouse) (aa100-112) antibody |
|||
| STJ72520 | St John's Laboratory | 100 µg | EUR 359 |
Anti Human Galectin-3 Polyclonal Antibody |
|||
| KH040 | Sceti | EUR 649 | |
|
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur. |
|||
Anti-Galectin-1 / Human Placental Lactogen (hPL) Monoclonal Antibody |
|||
| M00470 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Mouse Monoclonal Galectin-1 / Human Placental Lactogen (hPL) Antibody. Validated in IHC and tested in Human. |
|||
Galectin-1 (LGAS1) |
|||
| PR27143 | Neuromics | 50 ug | EUR 318 |
Galectin 1 Antibody |
|||
| 49673-100ul | SAB | 100ul | EUR 333 |
Galectin 1 Antibody |
|||
| 49673-50ul | SAB | 50ul | EUR 239 |
Galectin-1 Protein |
|||
| 20-abx261634 | Abbexa |
|
|
Galectin-1 Protein |
|||
| 20-abx263505 | Abbexa |
|
|
rHu Galectin-1 |
|||
| AK8281-0010 | Akron Biotech | 10µg | Ask for price |
Spread of the COVID-19 global pandemic highlights the urgent need to develop effective treatments or vaccines against SARS-CoV-2 infection.
The identification of novel antibodies to neutralize the virus is one of the approaches to fight COVID-19 . In particular, detect an antibody against the SARS-CoV-2 spike protein by building on knowledge about the existing structure of SARS-CoV-2 and learnings from previous SARS antibody generations.
Potent neutralizing antibodies often target the receptor interaction site in S1, disabling receptor interactions. The so-called spike protein of 2019-nCoV is used by the virus to dock to human cells. By targeting the protein, to prevent the infection.
COVID-19 patients developed SARS-CoV-2-specific NAbs at the convalescent phase of infection (SARS-CoV-2 NAbs were unable to cross-reactive with SARS-CoV virus). SARS-CoV -2 specific NAbs reached their peak in patients from day 10-15 after the onset of the disease and remained stable thereafter in the patients.
Antibodies targeting on different domains of S protein, including S1, RBD, and S2, may all contribute to the neutralization.
Neutralizing antibodies (NAbs) play important roles in virus clearance and have been considered as a key immune product for protection or treatment against viral diseases.
Virus-specific NAbs, induced through either infection or vaccination, can block viral infection .
NAbs confer immunity by deactivate viruses by block access to receptors used by the virus to enter host cells and bind to viral capsid and block uncoating of the viral genome .
The level of NAbs has been used as a gold standard to evaluate the efficacy of vaccines against smallpox, polio and influenza viruses .
Passive antibody therapy, such as plasma fusion, was successfully used to treat infectious viral diseases, including SARS-CoV virus, influenza viruses, and Ebola virus.
The efficacy of passive antibody therapy was associated with the concentration of NAbs in plasma or antibodies of recovered donors.
As the global pandemic of COVID-19 proceeds, transfusion of convalescent plasma or serum from recovered patients was also considered as a promising therapy for prophylaxis of infection or treatment of disease.
Highly variable levels of NAbs in the patients of COVID-19 indicated that convalescent plasma and serum from recovered donors should be titrated before use in passive antibody therapy, an easy task that can be performed using the PsV neutralization assay. The titers of NAbs were variable in different patients.
Elderly patients (60-80 ys) were more likely to induce higher titers of NAbs than younger patients.
A moderatepositive correlation was also observed between age and Nab titers confirming the important role of age in the generation of Nabs. The correlation of NAbs titers with age, lymphocyte counts, and blood CRP levels suggested that the interplay between virus and host immune response.
Alpha-bungarotoxin, CF680r |
|||
| 9-00003 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF640r |
|||
| 9-00004 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF640r |
|||
| 9-00004 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF488a |
|||
| 9-00005 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin CF488a |
|||
| 9-00005 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF568 |
|||
| 9-00006 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF568 |
|||
| 9-00006 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin |
|||
| 00010-1 | Biotium | 1MG | EUR 168 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Fluorescein-Alpha-bungarotoxin |
|||
| 00011 | Biotium | 500uG | EUR 367 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Tetramethylrhodamine-Alpha-bungarotoxin |
|||
| 00012 | Biotium | 500uG | EUR 383 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
| 00013 | Biotium | 10ST | EUR 417 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
| 00014 | Biotium | 10ST | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
| 00015 | Biotium | 500uG | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
| 00016 | Biotium | 10ST | EUR 523 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Biotin-xx-a-bungarotoxin |
|||
| 00017 | Biotium | 500uG | EUR 433 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Biotin-cAMP, diisopropylethylammonium salt: |
|||
| 00020 | Biotium | 1MG | EUR 314 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00020-1 | Biotium | 20ST | EUR 418 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Biotin-cGMP, diisopropylethylammonium salt: |
|||
| 00021 | Biotium | 1MG | EUR 344 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00021-1 | Biotium | 20ST | EUR 448 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Cyanine 644-cAMP: |
|||
| 00022 | Biotium | 1MG | EUR 491 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Cyanine 644-cAMP: (20x50ug) |
|||
| 00022-1 | Biotium | 20ST | EUR 625 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Fluorescein Methotrexate, triammonium salt: |
|||
| 00023 | Biotium | 1MG | EUR 281 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 139 |
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF543 |
|||
| 00026 | Biotium | 500uG | EUR 494 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Rhodamine phalloidin 300u |
|||
| 00027 | Biotium | 300 | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300 |
|||
Biotin-xx-phalloidin |
|||
| 00028 | Biotium | 100U | EUR 428 |
|
Description: Minimum order quantity: 1 unit of 100U |
|||
Fluorescein-phalloidin |
|||
| 00030 | Biotium | 300U | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Rhodamine 110 phalloidin |
|||
| 00032 | Biotium | 300ST | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300ST |
|||
Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
| 00033 | Biotium | 300EU | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300EU |
|||
Phalloidin, CF405M |
|||
| 00034 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF405M |
|||
| 00034-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
CF488A-cAMP |
|||
| 00036 | Biotium | 100ug | EUR 172 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
CF640R-cAMP |
|||
| 00037 | Biotium | 100ug | EUR 172 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Phalloidin, CF555 |
|||
| 00040 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF555 |
|||
| 00040-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF647 |
|||
| 00041 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF647 |
|||
| 00041-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF488A |
|||
| 00042 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF488A |
|||
| 00042-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF543 |
|||
| 00043 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF543 |
|||
| 00043-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF568 |
|||
| 00044 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF568 |
|||
| 00044-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF594 |
|||
| 00045 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF594 |
|||
| 00045-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF633 |
|||
| 00046 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF633 |
|||
| 00046-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660R |
|||
| 00047 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660R |
|||
| 00047-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680R |
|||
| 00048 | Biotium | 300U | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680R |
|||
| 00048-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF350 |
|||
| 00049 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF350 |
|||
| 00049-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF640R |
|||
| 00050 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF640R |
|||
| 00050-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF532 |
|||
| 00051 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF532 |
|||
| 00051-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660C |
|||
| 00052 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660C |
|||
| 00052-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680 |
|||
| 00053 | Biotium | 300U | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680 |
|||
| 00053-T | Biotium | 50U | EUR 147 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF430 |
|||
| 00054 | Biotium | 300U | EUR 449 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF430 |
|||
| 00054-T | Biotium | 50U | EUR 139 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF440 |
|||
| 00055 | Biotium | 300U | EUR 449 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF440 |
|||
| 00055-T | Biotium | 50U | EUR 139 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Cholera Toxin Subunit B, CF488A conjugate |
|||
| 00070 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF568 conjugate |
|||
| 00071 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF594 conjugate |
|||
| 00072 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF640R conjugate |
|||
| 00073 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF532 conjugate |
|||
| 00074 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF543 conjugate |
|||
| 00075 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF620R conjugate |
|||
| 00076 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF633 conjugate |
|||
| 00077 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF660R conjugate |
|||
| 00078 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF680R conjugate |
|||
| 00079 | Biotium | 100ug | EUR 282 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Human Transferrin, CF488A conjugate |
|||
| 00081 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF543 conjugate |
|||
| 00082 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||